GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (STU:0OG) » Definitions » Intrinsic Value: Projected FCF

Organigram Global (STU:0OG) Intrinsic Value: Projected FCF : €-1.90 (As of Jun. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Organigram Global Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-03), Organigram Global's Intrinsic Value: Projected FCF is €-1.90. The stock price of Organigram Global is €1.13. Therefore, Organigram Global's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Organigram Global's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 12 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Organigram Global was 976.00. The lowest was 45.67. And the median was 87.84.

STU:0OG's Price-to-Projected-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.62
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Organigram Global Intrinsic Value: Projected FCF Historical Data

The historical data trend for Organigram Global's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global Intrinsic Value: Projected FCF Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.48 -4.51 -2.44 -3.45 -6.25

Organigram Global Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.84 -5.35 -6.25 -2.65 -1.91

Competitive Comparison of Organigram Global's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Organigram Global's Price-to-Projected-FCF falls into.


;
;

Organigram Global Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Organigram Global's Free Cash Flow(6 year avg) = €-51.55.

Organigram Global's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar25)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-51.55408+251.653*0.8)/133.509
=-2.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organigram Global  (STU:0OG) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Organigram Global's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=1.13/-2.1683224936633
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organigram Global Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Organigram Global's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Organigram Global Headlines

No Headlines